The prediagnostic general practitioner care of sarcoma patients: A real‐world data study
Journal of Surgical Oncology · 2024
DOI: 10.1002/jso.27757 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Emily I Holthuis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Sarcoma, General Practitioners. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Limited understanding exists regarding early sarcoma symptoms presented during general practitioner (GP) consultations. The study explores GP visit patterns and recorded diagnoses in the 12 months preceding sarcoma diagnosis.
Methods
Sarcoma cases diagnosed from 2010 to 2020 were identified through the Netherlands Cancer Registry alongside general practice data. Sarcoma cases were age and gender matched to cancer‐free controls (2:1 or 1:1 ratio).
Results
A total of 787 individuals with soft‐tissue sarcoma (STS) and 188 individuals with bone sarcoma (BS) were identified. There was a significant difference in monthly GP contacts from 4 months to the last month before STS diagnosis, and 2 months before BS diagnosis between cases and controls. Most prevalent diagnoses recorded by the GP for STS cases included musculoskeletal neoplasm (26.6%), uncomplicated hypertension (15.6%), and cystitis/other urinary infections (12.2%). For BS cases, musculoskeletal neoplasm (42.8%), knee symptoms/complaints (9.7%), and shoulder symptoms/complaints (9.7%) were most frequent. Conclusions and Discussion A significant difference in GP contacts between cases and controls preceding sarcoma diagnosis. STS cases were predominantly diagnosed with nonspecific symptoms, whereas BS cases with diagnoses more suggestive of BS. Better understanding of the prediagnostic trajectory could aid GPs in early identification of sarcoma
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Oncology Department, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
- Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
- Department of Primary and Community Care, Radboud Institute of Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
- Surgical Oncology Department, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
- Department of Primary Care, Netherlands Institute for Health Services Research (Nivel), Utrecht, The Netherlands.
- Department of Surgical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Zitieren
APA
Holthuis, E. I., van der Graaf, W. T. A., Drabbe, C., van Houdt, W. J., Schrage, Y. M., Hartman, T. C. O., Uijen, A. A., Bos, I., Heins, M., Husson, O., & and other members of the Study Group (2024). The prediagnostic general practitioner care of sarcoma patients: A real‐world data study. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27757
Vancouver
Holthuis EI, van der Graaf WTA, Drabbe C, van Houdt WJ, Schrage YM, Hartman TCO, et al. The prediagnostic general practitioner care of sarcoma patients: A real‐world data study. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27757
BibTeX
@article{Holthuis2024,
author = {Holthuis, Emily I and van der Graaf, Winette T A and Drabbe, Cas and van Houdt, Winan J and Schrage, Yvonne M and Hartman, Tim C Olde and Uijen, Annemarie A and Bos, Isabelle and Heins, Marianne and Husson, Olga and and other members of the Study Group, and other members of the Study Group},
title = {The prediagnostic general practitioner care of sarcoma patients: A real‐world data study},
journal = {Journal of Surgical Oncology},
year = {2024},
doi = {10.1002/jso.27757}
}
EUVIMED